Georgian Technology News
SEE OTHER BRANDS

Your science and technology news reporter from the country of Georgia

Georgian Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Georgian Technology News.

Press releases published on August 20, 2025

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier

NANTES, France - 20 août 2025, 18 h 00 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce aujourd’hui la nomination de Thomas Gidoin au poste de Directeur Financier. Thomas rejoint le Comité Exécutif, apportant à la Société plus de 15 …

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula, MyndMed™, has been officially certified clean by …

BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Second Fast Track designation in recent months highlights broad potential of rhu-pGSN across …

Sift’s Fall ’25 Release: Advanced Fraud Investigation Tooling to Simplify Fraud Management & Strengthen Identity Trust

Sift’s Fall ’25 Release: Advanced Fraud Investigation Tooling to Simplify Fraud Management & Strengthen Identity Trust

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sift, the AI-powered fraud platform delivering identity trust, today announced innovations to simplify risk decisioning as fraud attacks escalate, adding pre-built workflows, refined policy abuse detection, …

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates to the fourth quarter of 2025 for two EYLEA HD® ( …

Sidero Labs Achieves SOC 2 Type II Certification, Reinforcing Enterprise-Grade Security and Operational Integrity

Sidero Labs Achieves SOC 2 Type II Certification, Reinforcing Enterprise-Grade Security and Operational Integrity

GOLETA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sidero Labs, delivering solutions that reduce friction in managing Kubernetes and containerized applications, today announced it has successfully completed its SOC 2 Type II audit. The independent …

Life360 Launches No Show Alerts to Ease Parents’ Back-To-School Scheduling Stress

Life360 Launches No Show Alerts to Ease Parents’ Back-To-School Scheduling Stress

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Life360 (Nasdaq: LIF; ASX: 360), the leading family connection and safety company, today announced No Show Alerts, a new feature designed to give parents peace of mind without having to constantly check in. …

Bybit Announces Launch of TradFi Platform for South African Traders

Bybit Announces Launch of TradFi Platform for South African Traders

Dubai, UAE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Bybit has introduced TradFi, a new service designed to change how traders engage with the markets. It enables local traders to access multiple asset classes, earn passive income, and utilise professional-grade …

ProSearch Achieves Relativity aiR for Review Competency, Reinforcing AI-Powered Document Review Leadership

ProSearch Achieves Relativity aiR for Review Competency, Reinforcing AI-Powered Document Review Leadership

LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ProSearch, a leading provider of comprehensive discovery and compliance solutions to corporate legal departments and law firms, announces it has earned the Relativity aiR for Review solution competency. This …

Metrc Launches Direct-to-Consumer Product Recall Feature via Metrc Retail ID™ in California

Metrc Launches Direct-to-Consumer Product Recall Feature via Metrc Retail ID™ in California

LAKELAND, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Metrc, a leading provider of regulatory track-and-trace systems for highly regulated industries, announced a groundbreaking enhancement to its Metrc Retail ID™ solution, enabling direct-to-consumer product …

Ironvale Bitcore: This Ironvale Bitcore Trading Platform Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval

Ironvale Bitcore: This Ironvale Bitcore Trading Platform Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval

Gatineau, QC, Aug. 20, 2025 (GLOBE NEWSWIRE) -- In 2025, the digital trading landscape continues to evolve at an unprecedented pace, and platforms leveraging artificial intelligence and high-level security frameworks are gaining industry attention. Among …

Dealer Alchemist Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies for Fourth Consecutive Year

Dealer Alchemist Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies for Fourth Consecutive Year

LONE TREE, Colo., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dealer Alchemist, an industry leader in automotive digital marketing solutions, today announced its recognition on the annual Inc. 5000 list, ranking No. 1302 with an impressive 337% three-year growth …

Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy

Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy

LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …

ROG Xbox Ally and ROG Xbox Ally X to Hit Canadian Stores on October 16

ROG Xbox Ally and ROG Xbox Ally X to Hit Canadian Stores on October 16

Gaming handhelds will be on show for the very first time at Gamescom 2025 KEY POINTS Ready for launch: On-shelf availability of ROG Xbox Ally and ROG Xbox Ally X slated for October 16, 2025 Optimized for handheld gaming: Xbox team has developed a new …

BlueQubit: This BlueQubit Trading Robot Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval

BlueQubit: This BlueQubit Trading Robot Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval

Gatineau, QC, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Introduction In the rapidly evolving landscape of financial technology, one name is making a decisive impact in 2025: BlueQubit. Positioned as a next-generation trading robot, BlueQubit combines AI-driven …

PrimeEnergy Resources Corporation Reports Second Quarter and First Half 2025 Results

PrimeEnergy Resources Corporation Reports Second Quarter and First Half 2025 Results

HOUSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- PrimeEnergy Resources Corporation (NASDAQ: PNRG) today announced financial results for the second quarter and first half of 2025. While year-over-year revenue and earnings declined due to lower oil prices, the …

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …

Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced …

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …

Wrap Technologies Introduces WrapTactics™: Digital Training Platform Driving BolaWrap® Adoption and Shifting Policing Toward Pre-Escalation Training

Wrap Technologies Introduces WrapTactics™: Digital Training Platform Driving BolaWrap® Adoption and Shifting Policing Toward Pre-Escalation Training

MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in pre-escalation and public safety solutions, today announced the official launch of WrapTactics™, a subscription-driven digital …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions